VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: don roberson who wrote (2497)	11/14/1997 4:23:00 PM
From: BigKNY3	Read Replies (3) of 23519

It's June, 1998, you are a primary care physician (and non-VVUS shareholder)..You have been seeing a particular older patient for years but he tells you for the first time that he has an ED problem...You have the option of prescribing MUSE or a newly approved oral agent that is priced at a substantial discount to MUSE. Which product will the physician find easier to discuss and prescribe to this patient? What will be the potential greater fear for the patient; the fear of diarrhea, the fear of long-term side effects or the fear of placing a pellet into the penis? BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next